During the past decade, Hospital de Sabadell conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Sabadell" #1 sponsor was "Corporacion Parc Tauli" with 5 trials, followed by "Agennix" with 2 trials sponsored, "Grupo Espanol Multidisciplinario del Cancer Digestivo" with 2 trials sponsored, "Andromeda Biotech Ltd." with 1 trials sponsored and "Asahi Kasei Pharma America Corporation" with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Sabadell" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "AGO Study Group" with 1 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Belgian Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Sabadell" are "Severe Sepsis" (3 trials), "Asthma" (1 trials), "Atherosclerosis" (1 trials), "Bowel Preparation for Colonoscopy" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "Hospital de Sabadell" in a lesser frequency.

Most popular intervention types in "Hospital de Sabadell" are "Drug" (18 trials), "Other" (4 trials), "Behavioral" (3 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Docetaxel" (2 trials), "Talactoferrin alfa" (2 trials), "Usual care" (2 trials) and "5Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Sabadell" are 22 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital de Sabadell". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Hospital de Sabadell, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Sabadell, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 3 trials that are defined as “Not Applicable".